Global Deep Brain Stimulation Devices Market - 2025-2033

Deep Brain Stimulation Devices Market Size

Deep Brain Stimulation Devices Market Size reached US$ 866.46 Million in 2024 and is expected to reach US$ 1,877.50 Million by 2033, growing at a CAGR of 9.0% during the forecast period 2025-2033.

Deep Brain Stimulation Devices Market The deep brain stimulation devices market is experiencing steady and significant growth driven by the global rise in neurological disorders, technological innovation, and expanding healthcare infrastructure. Deep brain stimulation devices are surgically implanted neurostimulators that deliver electrical impulses to specific targets in the brain, primarily used for treating movement disorders such as Parkinson’s disease, essential tremor, and dystonia, as well as psychiatric conditions like OCD and depression.

Technological advancements are playing a pivotal role in market expansion. Innovations such as MRI-compatible devices, directional leads, closed-loop systems, and rechargeable batteries are enhancing treatment precision, reducing surgical risks, and improving patient comfort and compliance. Integration of wireless and Bluetooth technologies for device monitoring is also becoming more prevalent. Stakeholders that invest in innovation, patient education, and market penetration strategies, especially in underserved regions, are likely to see significant returns in the coming years.

Deep Brain Stimulation Devices Market Dynamics: Drivers & Restraints

Rising technological advancements in DBS devices are significantly driving the market growth

Earlier DBS systems posed safety concerns during MRI scans, which are critical for long-term neurological monitoring. Modern systems like Medtronic’s Percept PC and Boston Scientific’s Vercise Genus are MRI-conditional, enabling safe imaging and thus greater adoption among clinicians and patients. The rising advancements by major market players in these devices are boosting their adoption, which is further driving the market growth.

For instance, in February 2025, Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI). Medtronic has enhanced its Percept DBS neurostimulators with exclusive BrainSense Adaptive technology, introducing a DBS for people living with Parkinson's. This feature personalizes therapy based on a patient's brain activity in real time, both in clinical settings and in daily life. It provides enhanced therapy personalization for symptom control that automatically adjusts, minimizing the need for patients to manually adjust stimulation.

Traditional DBS leads deliver current in all directions, potentially stimulating unintended brain areas and causing side effects. Advanced systems like Abbott’s Infinity DBS System feature directional leads, allowing physicians to steer the current more precisely to target regions. This leads to better outcomes and fewer complications, especially in complex conditions like dystonia or tremor. Companies are increasingly exploring AI-based analytics to personalize DBS therapy further. Data collected by sensing-enabled devices can be analyzed to optimize stimulation patterns, improving long-term outcomes and enhancing clinical decision-making.

High procedural and device cost is hampering the deep brain stimulation devices market

The high cost of deep brain stimulation devices and procedures is a significant factor that hampers market growth by limiting access and affordability for a large segment of potential patients. This financial barrier affects adoption rates, particularly in low- and middle-income regions, and impacts both healthcare providers and patients.

For instance, according to the National Institute of Health, 2024, the inflation and currency-adjusted mean cost of the DBS device was USD 21,496.07 ± USD 8,944.16, the cost of surgery alone was USD 14,685.22 ± USD 8,479.66, the total cost of surgery was USD 40,942.85 ± USD 17,987.43 and the total cost of treatment until 1 year of follow-up was USD 47,632.27 ± USD 23,067.08.

Given the high costs, some patients may opt for less effective but more affordable treatments, even if they do not provide the same symptom relief as deep brain stimulation. Non-surgical options, such as medication, physical therapy, or non-invasive brain stimulation techniques, are generally much less expensive than DBS. This preference for more affordable alternatives further constrains the DBS market, particularly among those who prioritize cost over treatment efficacy.

Deep Brain Stimulation Devices Market Segment Analysis

The global deep brain stimulation devices market is segmented based on product type, battery type, stimulation type, application, end-user, and region.

The movement disorders from the application segment are expected to hold 28.12% of the market share in 2024 in the deep brain stimulation devices market

Deep brain stimulation is particularly effective in managing symptoms associated with conditions like Parkinson's disease, essential tremor, and dystonia, where it has become an established treatment option due to its ability to provide significant, sustained symptom relief. These effective benefits associated with deep brain stimulation for movement disorders encourage manufacturers to launch DBS systems with advanced features.

For instance, in January 2024, Abbott received approval from the U.S. Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation system, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system also requires the fewest recharges of any FDA-approved DBS system, needing only 10 recharge sessions a year for most people.

Parkinson's disease is one of the most prevalent movement disorders, affecting more than 10 million people worldwide, with approximately 90,000 new cases diagnosed each year in the United States alone, according to the Parkinson's Foundation. The prevalence is anticipated to rise significantly as the global population ages. This large and growing patient base has made Parkinson's disease the primary condition treated with deep brain stimulation.

Deep Brain Stimulation Devices Market Geographical Analysis

North America is expected to dominate the global deep brain stimulation devices market with a 44.17% share in 2024

The North America region is expected to hold the largest market share over the forecast period, owing to the technological advancements and high rate of adoption of deep brain stimulation devices and procedures. For instance, according to Orlando Neurosurgery, approximately 12,000 DBS procedures occur in the United States each year.

North American companies are at the forefront of introducing next-generation DBS devices that offer improved efficacy and patient comfort. Innovations such as rechargeable batteries, remote programming, and adaptive deep brain stimulation are gaining traction and are widely adopted in the region, especially in the United States. These advancements not only improve patient outcomes but also make deep brain stimulation more appealing to a broader patient base.

There is a rising prevalence of various movement and psychiatric disorders in North America, especially in the United States, further increasing the demand for deep brain stimulation devices and procedures in the region. For instance, according to the Parkinson's Foundation, nearly one million people in the U.S. are living with Parkinson's disease (PD). This number is expected to rise to 1.2 million by 2030. Nearly 90,000 people in the U.S. are diagnosed with PD each year.

Deep Brain Stimulation Devices Market Top Companies

Top companies in the deep brain stimulation devices market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Aleva Neurotherapeutics, NeuroPace, Inc., SceneRay Co., Ltd., PINS Medical, Renishaw plc., BrainsWay Ltd., and inomed Medizintechnik GmbH, among others.

Key Developments

In February 2025, Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI). Medtronic has enhanced its Percept DBS neurostimulators with exclusive BrainSense Adaptive technology, introducing a DBS for people living with Parkinson's. This feature personalizes therapy based on a patient's brain activity in real time, both in clinical settings and in daily life. It provides enhanced therapy personalization for symptom control that automatically adjusts, minimizing the need for patients to manually adjust stimulation.

In April 2024, Medtronic India launched its NeuroSmartTM Portable Micro Electrode Recording (MER) Navigation system for Deep Brain Stimulation (DBS) to treat Parkinson’s disease. The NeuroSmartTM Portable MER Navigation system, developed by Alpha Omega Engineering, features advanced neurophysiological navigation mapping and enables accurate electrode placement while recording neural activity. Its advanced capabilities for enhanced target localization, based on HaGuide automatic navigation, help identify the most effective target for the patient, ensuring optimum symptom relief.

In August 2024, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for Asleep Deep Brain Stimulation (DBS) surgery for people with Parkinson’s and people with essential tremors. Medtronic is the first and only company to receive FDA approval to offer DBS surgery while a patient is asleep (under general anesthesia) or awake.

In September 2024, Abbott launched a pivotal clinical trial to see if its deep brain stimulation approach can make headway against treatment-resistant depression. The company previously collected green lights for brain neuromodulation systems that help treat the movement symptoms that come with Parkinson’s disease and essential tremor, as well as for implants that focus on the spinal cord to aid in cases of chronic pain. The devices send small electrical pulses to spur tissue activity, not unlike a pacemaker.

The global deep brain stimulation devices market report delivers a detailed analysis with 78 key tables, more than 74 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.


1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
3. Market Highlights and Strategic Takeaways
3.1. Key Trends and Future Projections
4. Snippet by Product Type
4.1. Snippet by Battery Type
4.2. Snippet by Stimulation Type
4.3. Snippet by Application
4.4. Snippet by End-User
4.5. Snippet by Region
5. Dynamics
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Neurological and Psychiatric Disorders
5.1.1.2. Rising Technological Advancements in DBS Devices
5.1.1.3. Integration of Real-Time Brain Sensing
5.1.2. Restraints
5.1.2.1. High Procedural and Device Cost
5.1.2.2. Invasiveness and Surgical Risks
5.1.2.3. Psychological and Cognitive Side Effects
5.1.3. Opportunity
5.1.3.1. Expansion into Psychiatric and Cognitive Disorders
5.1.3.2. AI-Driven Personalization and Predictive Analytics
5.1.4. Impact Analysis
6. Strategic Insights and Industry Outlook
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. South America
6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Pricing Analysis and Price Dynamics
7. Deep Brain Stimulation Devices Market, By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Single-Channel Systems*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dual-Channel Systems
8. Deep Brain Stimulation Devices Market, By Battery Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
8.1.2. Market Attractiveness Index, By Battery Type
8.2. Rechargeable Systems*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Non-Rechargeable Systems
9. Deep Brain Stimulation Devices Market, By Stimulation Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
9.1.2. Market Attractiveness Index, By Stimulation Type
9.2. Constant Current Devices*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Voltage-Controlled Devices
10. Deep Brain Stimulation Devices Market, By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Movement Disorders*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2.3. Parkinson's Disease
10.2.4. Dystonia
10.2.5. Essential Tremor
10.2.6. Others
10.3. Psychiatric Disorders
10.3.1. Obsessive-Compulsive Disorder (OCD)
10.3.2. Depression
10.3.3. Others
10.4. Epilepsy
10.5. Chronic Pain
10.6. Alzheimer's Disease
10.7. Tourette Syndrome
10.8. Others
11. Deep Brain Stimulation Devices Market, By End-User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals and Clinics*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Neurological Centers
11.4. Ambulatory Surgical Centers
11.5. Others
12. Deep Brain Stimulation Devices Market, By Regional Market Analysis and Growth Opportunities
13. Introduction
13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.1. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.8.1. U.S.
13.2.8.2. Canada
13.2.8.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.8.1. Germany
13.3.8.2. UK
13.3.8.3. France
13.3.8.4. Spain
13.3.8.5. Italy
13.3.8.6. Rest of Europe
13.4. Asia-Pacific
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.8.1. China
13.4.8.2. India
13.4.8.3. Japan
13.4.8.4. South Korea
13.4.8.5. Rest of Asia-Pacific
13.5. South America
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.8.1. Brazil
13.5.8.2. Argentina
13.5.8.3. Rest of South America
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Battery Type
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stimulation Type
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
14. Competitive Landscape and Market Positioning
15. Competitive Overview and Key Market Players
15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking
16. Company Profiles
16.1. Medtronic plc*
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.2.1. Product Description
16.1.2.2. Product Key Performance Indicators (KPIs)
16.2. Financial Overview
16.2.1. Company Revenue
16.2.1.1. Geographical Revenue Shares
16.2.1.1.1. Revenue Forecasts
16.2.1.2. Key Developments
16.2.1.2.1. Mergers & Acquisitions
16.2.1.2.2. Key Product Development Activities
16.2.1.2.3. Regulatory Approvals, etc.
16.2.1.3. SWOT Analysis
16.2.2. Boston Scientific Corporation
16.2.3. Abbott Laboratories
16.2.4. Aleva Neurotherapeutics
16.2.5. NeuroPace, Inc.
16.2.6. SceneRay Co., Ltd.
16.2.7. PINS Medical
16.2.8. Renishaw plc.
16.2.9. BrainsWay Ltd.
16.2.10. inomed Medizintechnik GmbHLIST NOT EXHAUSTIVE
17. Assumption and Research Methodology
17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation
18. Appendix
18.1. About Us and Services
18.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings